Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 0 | |
Outperform | 5 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 4 analysts offering 12 month price targets for Syros Pharmaceuticals Inc have a median target of 10.00, with a high estimate of 20.00 and a low estimate of 4.00. The median estimate represents a 405.05% increase from the last price of 1.98.
High | 910.1% | 20.00 |
Med | 405.1% | 10.00 |
Low | 102.0% | 4.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 12, 2024.
Average growth rate | -114.26% |
Average growth rate | +23.88% |
More ▼
Revenue history & estimates in USD
Average growth rate | -39.23% |
Average growth rate | +161.81% |
More ▼